Advertisement

Differentiation induction in myeloid leukemic cells

  • Urban Gullberg
  • Kristina Peetre
  • Inge Olsson
Review
  • 19 Downloads

Abstract

Work based on immortalised leukemic cell lines indicates that the maturation arrest in leukemia can be reversible. Successful differentiation induction would mean restoring the link between proliferation and differentiation. Human cell lines such as the promyelocytic HL-60 and the monoblastic U-937 can be induced to mature by incubation with a wide variety of agents, e.g. phorbol diesters, retinoic acid and 1,25-dihydroxycholecalciferol. In addition, mitogen-stimulated lymphocytes and some T-lymphocyte lines produce a polypeptide called the differentiation-inducing factor (DIF), which mediates maturation of HL-60 into macrophage-like cells with resulting proliferation inhibition. DIF also displays a primary growth inhibitory effect on certain subclones of the cell lines as well as on fresh clonogenic cells from patients with acute myeloid leukemia and on normal granulocyte-macrophage progenitors. Our data indicate that there is more than one way to induce differentiation in leukemia but final common pathways may exist. Complementary, synergistic, maturation effects are seen between some agents, which may become of clinical utility.

Key words

Myeloid leukemia Differentiation-inducing factor Lymphokine Differentiation Hemopoiesis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Greaves M F: Immunobiology of lymphoid malignancy.Haemat Blood Transfus 28, 3 (1983).Google Scholar
  2. 2.
    Olofsson T, Olsson I: Supression of normal granulopoiesisin vitro by a leukemia associated inhibitor (LAI) of acute and chronic leukemia.Blood 55, 975 (1980).PubMedGoogle Scholar
  3. 3.
    Olofsson T, Olsson I: Biochemical characterization of a leukemia associated inhibitor (LAI) suppressing normal granulopoiesisin vitro.Blood 55, 983 (1980).PubMedGoogle Scholar
  4. 4.
    Sachs L: Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukemia.Nature 274, 535 (1978).PubMedCrossRefGoogle Scholar
  5. 5.
    Collins S J, Gallo R C, Gallagher R E: Continuous growth and differentiation of human myeloid leukemic cells in suspension culture.Nature (Lond) 270, 347 (1977).CrossRefGoogle Scholar
  6. 6.
    Sundström C, Nilsson K: Establishment and characterization of a human histiocytic lymphoma cell-line (U-937).Int J Cancer 7, 656 (1976).Google Scholar
  7. 7.
    Lozzio C B, Lozzio B B: Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.Blood 45, 321 (1975).PubMedGoogle Scholar
  8. 8.
    Koeffler H P, Golde D W: Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity.Science 200, 1153 (1978).PubMedCrossRefGoogle Scholar
  9. 9.
    Ichikawa Y: Differentiation of a cell line of myeloid leukemia.J Cell Physiol 74, 223 (1969).PubMedCrossRefGoogle Scholar
  10. 10.
    Gootwine E, Webb C, Sachs L: Participation of myeloid leukemic cells injected into embryos in hematopoietic differentiation of adult mice.Nature 299, 64 (1982).CrossRefGoogle Scholar
  11. 11.
    Lotem J, Sachs L:In vivo inhibition of the development of myeloid leukemia by injection of macrophage-granulocyte-inducing protein.Int J Cancer 28, 375 (1981).PubMedCrossRefGoogle Scholar
  12. 12.
    Gootwine E, Webb C, Sachs L: Participation of myeloid leukaemic cells injected into embryos in haemopoietic differentiation in adult mice.Nature 299, 63 (1982).PubMedCrossRefGoogle Scholar
  13. 13.
    Till J E, McCulloch E A, Siminovitch L: A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells.Proc Natn Acad Sci, USA 51, 29 (1964).CrossRefGoogle Scholar
  14. 14.
    Metcalf D: The granulocyte-macrophage colony-stimulating factors.Science 229, 16 (1985).PubMedCrossRefGoogle Scholar
  15. 15.
    Bishop J M: Cancer genes come of age.Cell 32, 1018 (1983).PubMedCrossRefGoogle Scholar
  16. 16.
    Sherr C J, Rettenmier C W, Sacca R, Roussel M F, Look A T, Stanley E R: Thec-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.Cell 41, 665 (1985).PubMedCrossRefGoogle Scholar
  17. 17.
    Sachs L: Constitutive gene expression and restoration of the normal phenotype in malignant cells: a model for the origin and evolution of leukemia.Blood Cells 7, 31 (1981).PubMedGoogle Scholar
  18. 18.
    Moore M A S, Williams N, Metcalf D:In vitro colony formation by normal leukemic human hematopoietic cells; characterization of the colony-forming cells.J Natn Cancer Inst 50, 603 (1973).Google Scholar
  19. 19.
    Heldin C-H, Westermark B: Growth factors: mechanism of action and relation to oncogenes.Cell 37, 9 (1984).PubMedCrossRefGoogle Scholar
  20. 20.
    Friend C, Scher W, Holland J G, Sato T: Hemoglobin synthesis in murine virus-induced leukemic cellsin vitro: stimulation of erythroid differentiation by dimethyl sulfoxide.Proc Natl Acad Sci, USA 68, 378 (1971).PubMedGoogle Scholar
  21. 21.
    Metcalf D: Clonal analysis of the action of GM-CSF on the proliferation and differentiation of myelomonocytic leukemic cells.Int J Cancer 24, 616 (1979).PubMedCrossRefGoogle Scholar
  22. 22.
    Fibach E, Hayashi M, Sachs L: Control of normal differentiation of myeloid-leukemic cells to macrophages and granulocytes.Proc Natl Acad Sci, USA 70, 343 (1973).PubMedCrossRefGoogle Scholar
  23. 23.
    Metcalf D: Regulator-induced suppression of myelomonocytic leukemic cells: clonal analysis of early cellular events.Int J Cancer 30, 203 (1982).PubMedCrossRefGoogle Scholar
  24. 24.
    Gullberg U, Nilsson E, Einhorn S, Olsson I: Combination of interferon-γ and retinoic acid or 1α,25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937.Exp Hematol 13, 675 (1985).PubMedGoogle Scholar
  25. 25.
    Olsson I, Olofsson T, Mauritzon N: Characterization of mononuclear blood cell derived differentiation inducing factors (DIFs) for the human promyelocytic leukemic cell line HL-60.J Natn Cancer Inst 67, 1225 (1981).Google Scholar
  26. 26.
    Olsson I, Sarngadharan M C, Breitman T R, Gallo R C: Isolation and characterization of a T-lymphocyte derived differentiation inducing factor (DIF) for myeloid leukemic cells.Blood 63, 510 (1984).PubMedGoogle Scholar
  27. 27.
    Poiesz B J, Ruscetti F W, Gazdar A F, Bunn P A, Minna J D, Gallo R C: Isolation of type-C retrovirus particles from cultured and fresh lymphocytes of a patient with cutaneous T-cell lymphoma.Proc Natn Acad Sci, USA 77, 7415 (1980).CrossRefGoogle Scholar
  28. 28.
    Gustavsson A, Mitelman F, Olofsson T, Olsson I: The relationship between growth agar, karyotype and prognosis in acute non lymphocytic leukemia.Scand J Haemat 32, 351 (1984).PubMedGoogle Scholar
  29. 29.
    Aggarwal B B, Kohr W J, Hass P E W, Moffat B, Spencer S A, Henzel W J, Bringman T S, Nedwin G E, Goeddel D V, Harkins R N: Human tumor necrosis factor.J Biol Chem 260, 2345 (1985).PubMedGoogle Scholar
  30. 30.
    Aggarwal B B, Henzel W J, Moffat B, Kohr W J, Harkins R N: Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line.J Biol Chem 260 2334 (1985).PubMedGoogle Scholar
  31. 31.
    Olsson I, Breitman T R, Gallo R C: Priming of human myeloid leukemic cell lines (HL-60 and U-937) with retinoic acid for differentiation effects of cyclic AMP-inducing agents and a T-lymphocyte derived differentiation factor.Cancer Res 42, 3928, (1982).PubMedGoogle Scholar
  32. 32.
    Olsson I, Gullberg U, Ivhed I, Nilsson K: Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1α,25-dihydroxycholecalciferol.Cancer Res 53, 5862 (1983).Google Scholar
  33. 33.
    Kraft A S, Andersson W B: Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane.Nature 301, 621 (1983).PubMedCrossRefGoogle Scholar
  34. 34.
    Westin E H, Wong Staal F, Gelmann E P, Dalla Favera R, Papas T S, Lautenberger J A, Eva A, Reddy E P, Tronick S R, Aaronson S A, Gallo R C: Expression of cellular homologs of retroviralonc genes in human hematopoietic cells.Proc Natn Acad Sci, USA 79, 2490 (1982).CrossRefGoogle Scholar
  35. 35.
    Retsma P H, Rothberg P G, Astrin S M, Trial J, Bar-Schavit Z, Hall A, Teitelbaum S L, Kahn A J: Regulation ofmyc gene expression in HL-60 leukaemia cells by a vitamin D metabolite.Nature 306, 492 (1983).CrossRefGoogle Scholar
  36. 36.
    Mitchell R L, Zokas L, Schreiber R D, Verma I M: Rapid induction of the expression of proto-oncogenefos during human monocytic differentiation.Cell 40, 209 (1985).PubMedCrossRefGoogle Scholar
  37. 37.
    Knudson A G: Hereditary cancer, oncogenes, and antioncogenes.Cancer Res 45, 1437 (1985).PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 1986

Authors and Affiliations

  • Urban Gullberg
    • 1
  • Kristina Peetre
    • 1
  • Inge Olsson
    • 1
  1. 1.Division of Hematology, Department of MedicineUniversity of LundLundSweden

Personalised recommendations